Meyka Pro banner
iRhythm Technologies, Inc.

iRhythm Technologies, Inc. Fundamental Analysis (NASDAQ: IRTC)

IRTCNASDAQ
HealthcareMedical - Devices
$123.16
$2.19(1.75%)
U.S. Market opens in 3h 1m

iRhythm Technologies, Inc. Fundamental Analysis (NASDAQ: IRTC)

iRhythm Technologies, Inc. (NASDAQ: IRTC) shows moderate financial fundamentals with a PE ratio of -291.59, profit margin of -1.69%, and ROE of -8.97%. The company generates $0.8B in annual revenue with strong year-over-year growth of 26.24%.

Key Strengths

Cash Position14.59%
PEG Ratio-1.21
Current Ratio3.87

Areas of Concern

ROE-8.97%
Operating Margin-1.17%
We analyze IRTC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 21.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
21.5/100

We analyze IRTC's fundamental strength across five key dimensions:

Efficiency Score

Weak

IRTC struggles to generate sufficient returns from assets.

ROA > 10%
-1.28%

Valuation Score

Excellent

IRTC trades at attractive valuation levels.

PE < 25
-291.59
PEG Ratio < 2
-1.21

Growth Score

Excellent

IRTC delivers strong and consistent growth momentum.

Revenue Growth > 5%
26.24%
EPS Growth > 10%
61.71%

Financial Health Score

Moderate

IRTC shows balanced financial health with some risks.

Debt/Equity < 1
3.91
Current Ratio > 1
3.87

Profitability Score

Weak

IRTC struggles to sustain strong margins.

ROE > 15%
-897.16%
Net Margin ≥ 15%
-1.69%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is IRTC Expensive or Cheap?

P/E Ratio

IRTC trades at -291.59 times earnings. This suggests potential undervaluation.

-291.59

PEG Ratio

When adjusting for growth, IRTC's PEG of -1.21 indicates potential undervaluation.

-1.21

Price to Book

The market values iRhythm Technologies, Inc. at 22.18 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

22.18

EV/EBITDA

Enterprise value stands at 181.04 times EBITDA. This signals the market has high growth expectations.

181.04

How Well Does IRTC Make Money?

Net Profit Margin

For every $100 in sales, iRhythm Technologies, Inc. keeps $-1.69 as profit after all expenses.

-1.69%

Operating Margin

Core operations generate -1.17 in profit for every $100 in revenue, before interest and taxes.

-1.17%

ROE

Management delivers $-8.97 in profit for every $100 of shareholder equity.

-8.97%

ROA

iRhythm Technologies, Inc. generates $-1.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.28%

Following the Money - Real Cash Generation

Operating Cash Flow

iRhythm Technologies, Inc. produces operating cash flow of $85.92M, showing steady but balanced cash generation.

$85.92M

Free Cash Flow

iRhythm Technologies, Inc. produces free cash flow of $38.94M, offering steady but limited capital for shareholder returns and expansion.

$38.94M

FCF Per Share

Each share generates $1.18 in free cash annually.

$1.18

FCF Yield

IRTC converts 0.95% of its market value into free cash.

0.95%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-291.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.21

vs 25 benchmark

P/B Ratio

Price to book value ratio

22.18

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.99

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

3.91

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.87

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.09

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How IRTC Stacks Against Its Sector Peers

MetricIRTC ValueSector AveragePerformance
P/E Ratio-291.5931.50 Better (Cheaper)
ROE-8.97%422.00% Weak
Net Margin-1.69%19867.00% Weak
Debt/Equity3.910.53 Weak (High Leverage)
Current Ratio3.875.56 Strong Liquidity
ROA-1.28%1571.00% Weak

IRTC outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews iRhythm Technologies, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

144.35%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

11.85%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

609.67%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ